US drug companies and the NHS

US drug companies and the NHS

0 Anmeldelser
0
Episode
433 of 2054
Længde
18M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the BBC's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.

(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for US drug companies and the NHS

Other podcasts you might like ...